SFRP1 and central nervous system cancer: The above results imply that the MTE‐induced inhibition of glioma cells was realized through upregulation of SFRP1 by the lncMEG3/miR‐542‐3p axis, and the inhibition of the Wnt/β‐catenin pathway activation.